Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer, Stage IB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)Study completedNCT04294225
What this trial is testing

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
Mayo Clinic 161
Not applicableEnded earlyNCT01346579
What this trial is testing

Biomarkers in Tissue Samples From Older Women With Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 505
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387
What this trial is testing

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT04494958
What this trial is testing

Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Fundacion Oncosur 24
Not applicableStudy completedNCT00968214
What this trial is testing

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 364
Testing effectiveness (Phase 2)UnknownNCT01800422
What this trial is testing

Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage II Breast Cancer
Northwestern University 50
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Ended earlyNCT01980277
What this trial is testing

Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 68
Testing effectiveness (Phase 2)Ended earlyNCT04216472
What this trial is testing

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT04249622
What this trial is testing

Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT03872791
What this trial is testing

KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 52
Early research (Phase 1)Active Not RecruitingNCT03641755
What this trial is testing

Olaparib + Sapacitabine in BRCA Mutant Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 10
Not applicableStudy completedNCT00486525
What this trial is testing

Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors

Who this might be right for
Breast CancerDepressionFatigue+1 more
Ohio State University Comprehensive Cancer Center 200
Not applicableEnrolling By InvitationNCT07465497
What this trial is testing

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Who this might be right for
ChemobrainBreast CancerInflammatory Disease
Instituto Jalisciense de Cancerologia 80
Early research (Phase 1)WithdrawnNCT04205071
What this trial is testing

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+21 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01869764
What this trial is testing

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast Cancer+6 more
Wake Forest University Health Sciences 57
Early research (Phase 1)Ended earlyNCT02414776
What this trial is testing

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

Who this might be right for
Estrogen Receptor Positive Breast Cancer
Western Regional Medical Center 3
Not applicableStudy completedNCT00072293
What this trial is testing

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 931
Testing effectiveness (Phase 2)Study completedNCT00416403
What this trial is testing

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 35
Next Page